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Various investigators have attempted to overcome the shortage of available hematopoietic stem/progenitor
cells (HSPCs) by facilitating their engraftment after transplantation. Preconditioning of HSPCs with the
granulocyte-derived cationic peptide LL-37 has been suggested as a useful strategy to facilitate engraftment of
transplanted cells by enhancing their responsiveness to CXCL12. In this study, we evaluated whether LL-37
preconditioning is acceptable for clinical application. We found that the effect of LL-37 preconditioning
was speciﬁc to clonogenic cells and was mediated speciﬁcally by increased calcium inﬂux with the activation
of downstream signaling through mammalian target of rapamycin complex 1 (mTORC1). Because hyper-
activation of mTORC1 and the disruption of 50 adenosine monophosphate-activated protein kinase (AMPK)
are known to deplete HSPC pools, we compared the repopulation capacity of HSPCs preconditioned with LL-
37 and those preconditioned with AMPK activator (AICAR). In vivo competitive repopulation experiments
revealed that LL-37 preconditioning impairs long-term repopulation of transplanted HSPCs, suggesting that
this strategy might not acceptable for clinical applications in which long-term repopulation capacity is a
prerequisite. AICAR preconditioning dramatically enhanced the long-term repopulation of transplanted
HSPCs, however. Taken together, these results suggest that future strategies to ensure successful trans-
plantation outcomes should focus on protecting HSPCs from various stimuli during their homing to the bone
marrow niches rather than activating them before transplantation.
 2014 American Society for Blood and Marrow Transplantation.INTRODUCTION
Transplantation of hematopoietic stem/progenitor cells
(HSPCs) is used to treat patients with malignant and
nonmalignant disorders by reconstituting bone marrow
(BM) with healthy stem cells. The current strategy to pro-
mote successful hematopoietic recovery after trans-
plantation is to infuse greater numbers of HSPCs; however,
the number of cells available for transplantation is limited in
most cases. Although the expansion of HSPCs through
incubation with various factors has been attempted to
overcome the shortage of available sources [1-4], in vitro
expanded cells usually show signiﬁcantly reduced abilityedgments on page 1289.
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14.06.027to produce long-term hematopoietic reconstitution after
transplantation [5,6].
The interaction between CXCL12 and its receptor CXCR4
expressed on HSPCs has been implicated as a primary axis
governing HSPC homing and engraftment after trans-
plantation [7]. Therefore, a number of investigators have
explored strategies to facilitate HSPC engraftment by
enhancing the responsiveness of HSPCs to CXCL12. Recent
progress has highlighted the physiological signiﬁcance of
some compounds in leukapheresis products, including
the complement cascade cleavage fragment C3a [8] and
the granulocyte-derived cationic peptide LL-37 [9], which
enhance the responsiveness of HSPCs to CXCL12 in vitro and
in vivo. The preconditioning of HSPCs with these compo-
nents should be a useful approach to solving the HSPC
shortage problem [10].
It should be noted, however, that mobilized peripheral
blood (PB)ederived HSPCs, which provide rapid reconstitu-
tion like C3a- and LL-37epreconditioned HSPCs, have shownTransplantation.
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We cannot rule out the possibility that the preconditioning
strategy may impair the long-term repopulation capacity of
transplanted HSPCs, because those components are present
in the plasma of normal subjects and patients awaiting
transplantation.
HSPCs are usually in a quiescent state and adapt to the
hypoxicmicroenvironment by utilizing glycolysis rather than
mitochondrial oxidative phosphorylation in BM niches [12-
14]. They maintain a slow-cycling state to avoid cellular
damage from reactive oxygen species (ROS) and to ensure
life-long hematopoietic capacity [15,16]. In contrast to these
BM-resident quiescent HSPCs, ex vivo manipulated HSPCs
are subjected to a variety of stressors, including increases in
oxygen tension, ﬂuctuations in various nutrients and growth
factors, and accumulation of various metabolites, which can
affect their long-term repopulation capacity [17]. In fact, it
has been demonstrated that hyperactivation of mammalian
target of rapamycin complex 1 (mTORC1) drives HSPCs from
quiescence into rapid cycling with increased mitochondrial
biogenesis and elevated levels of ROS, resulting in premature
exhaustion of HSPCs [18,19]. Likewise, deletion of the 50
adenosine monophosphate-activated protein kinase (AMPK)
regulator liver kinase B1 (LKB1) was found to lead to deple-
tion of HSPC pools and impaired hematopoiesis [20-22]. The
main purpose of the present study was to evaluate whether
an LL-37 preconditioning strategy is an acceptable clinical
application for increasing BM reconstitution with a limited
number of HSPCs.MATERIALS AND METHODS
Animals
CD45.1 and CD45.2 C57BL/6 congenic male mice, maintained in our fa-
cility, were used in the experiments at age 8w12 weeks. The mice were
housed in sterilized microisolator cages and received autoclaved food and
water ad libitum. All animal experiments were approved by the Animal Care
and Use Committee of the Institute of Laboratory Animal Resources, Seoul
National University.BM Nucleated Cells
BM nucleated cells (BMNCs) were prepared by ﬂushing the femurs and
tibias of mice. Whole BM cells were suspended in BD Pharm Lyse buffer (BD
Biosciences, San Jose, CA) to remove RBCs, washed, and then resuspended
with appropriate assay media for further experiments.Hematopoietic Cell Lines
Human promyelocytic leukemic cell line HL-60 was obtained from the
Korea Cell Line Bank and maintained in RPMI 1640 medium supplemented
with 10% FBS and antibiotics in humidiﬁed atmosphere of 5% CO2 and 95%
air at 37C.Transwell Migration Assay
The transwell migration assay was performed as described previously
[9]. Unless indicated otherwise, the cells were brieﬂy resuspended in assay
media (RPMI 1640 containing 0.5% BSA, 0.5 mM calcium chloride, and
5.5 mM glucose) and equilibrated for 30 minutes at 37C. An assay medium
(650 mL) containing test reagents was added to the lower chambers of a
Costar transwell plate (Corning, Tewksbury, MA). Cells were resuspended in
assaymedium (1107 BMNCs or 2106 HL-60 cells/mL), after which 100 mL
of cell suspension was loaded on the upper chambers using 5-mm pore ﬁl-
ters, followed by a 3-hour incubation (37C, 5% CO2). Migrated cells from the
lower chambers were counted using a FACSAria II analyzer (BD Biosciences)
to score the migration of cells to the test regents.
For the scoring of clonogenic cell migration, cells harvested from the
lower chambers were plated in colony-forming units-macrophage (CFU-M)
colony-forming assays. Preconditioned cells were prepared by incubating
cells with each compound. These preconditioned cells were loaded onto the
upper chamber for the migration assay. In some experiments, precondi-
tioned cells were thoroughly washed before use. CXCL12 and LL-37 were
purchased from ProSpec (East Brunswick, NJ) and AnaSpec (Fremont, CA).CFU-M Colony-forming Assay
Migrated cells were resuspended in human methylcellulose base media
provided by the manufacturer (R&D Systems, Minneapolis, MN) supple-
mented with 10 ng/mL recombinant murine macrophage stimulating factor
(ProSpec) for the CFU-M assay. Cultures were incubated for 7 to 15 days, at
which time they were scored for the number of CFU-M colonies under an
inverted microscope.
Measurement of Cytosolic Free Calcium Changes
HL-60 cells were loaded with Fluo4 NW calcium-indicating dye (Mo-
lecular Probes, OR) according to the manufacturer’s instructions with some
modiﬁcation. In brief, HL-60 cells were loaded with calcium-indicating dye
for 30 minutes in 5% CO2 at 37C. After washing, the cells were resuspended
with RPMI 1640 medium containing 0.5% BSA (2  106 cells/mL) and then
loaded at 50 mL/well onto black 96-well plates with opaque bottoms
(Corning) with the same volume of LL-37econtaining (1000 nM), AMPK
activator (AICAR)-containing (4 mM), or control media, followed by incu-
bation for an additional 30 minutes in 5% CO2 at 37C. The plates were
transferred to a microplate reader (Inﬁnite F200 Pro; Tecan Group,
Switzerland). Fluorescencewas recorded at 37Cwith excitationwavelength
of 485 nm and an emission wavelength of 510 nm.
Immunoblotting
HL-60 cells were cultured with RPMI 1640 medium containing 10% FBS
and antibiotics in a humidiﬁed atmosphere of 5% CO2 and 95% air at 37C. In
some groups, calcium chloride was supplemented up to 4.5 mM. Protein
extracts were separated on a 10% sodium dodecyl sulfateepolyacrylamide
gel electrophoresis (SDS/PAGE) gel and then transferred to a nitrocellulose
membrane (Hybond ECL; Amersham Life Sciences, Little Chalfont, UK).
These extracts were probed with appropriate primary and secondary anti-
body pairs. Primary antibodies were p-4E-BP1, p-GSK-3b, caspase-3 (#9451,
#5558, and #9661, respectively; Cell Signaling Technology, Danvers, MA),
and b-actin (#A5441; Sigma-Aldrich, St Louis, MO). The membranes were
developed with an ECL reagent (Thermo Scientiﬁc, Rockford, IL), dried, and
then exposed to ﬁlm.
Proliferation Assays
For proliferation assays, HL-60 cells were ﬁrst resuspended in RPMI
1640 medium containing 5% FBS and additional calcium (up to 2.5 mM) in
the presence or absence of LL-37. The cell numbers were scored every
24 hours.
Competitive Repopulation Assay
BMNCs were prepared as described above. Isolated BMNCs from CD45.1
congenic C57BL/6 mice were preconditioned with LL-37 (500 nM), lithium
chloride (LiCl; 10 mM), AICAR (2 mM), or control media and mixed with
normal competitor BMNCs (1106) derived from CD45.2 congenic mice at a
1:1 ratio. Cells were injected through the tail vein of CD45.2 C57BL/6 mice
that were lethally irradiated at 1000 cGy approximately 18 hours before
transplantation.
Each transplantation group was consisted of 5 recipients. After trans-
plantation, PB samples were obtained to determine donor chimerism. Level
of chimerism was determined by the presence of CD45.1þ or CD45.2þ cells.
PB samples were obtained from the retroorbital plexus of recipients starting
at week 2. Complete blood counts were performed with a VetScan HM2
hematology system (Abaxis, Union City, CA). The PB samples were evaluated
by ﬂow cytometry analysis for quantiﬁcation of CD45.1þ and CD45.2þ cells
from the Gr-1þ population. After the lysis of RBCs, nucleated cell suspen-
sions were evaluated with a FACSAria II, using analyses designed to exclude
dead cells, debris, and platelets. Allophycocyanin-conjugated anti-mouse
CD45.1 (#17-0453), FITC-conjugated anti-mouse CD45.2 (11-0454), and PE-
conjugated anti-mouse Gr-1 (#12-5931) antibodies (all from eBioscience)
were used to stain the PB samples.
Statistical Analysis
Data are presented as mean and SEM unless noted otherwise. All dif-
ferences were analyzed using the Student t test. Statistical analysis for the
contribution of transplanted BMNCs in the hematopoietic repopulation was
performed using nonparametric methods [23] with the nparLD package in R
[24]. A P value <.05 was considered statistically signiﬁcant.
RESULTS
The LL-37 Preconditioning Effect is Speciﬁc to Clonogenic
Cells
Signiﬁcantly increased migration of HSPCs in response
to CXCL12 in the presence of LL-37 has been reported
H. Lee et al. / Biol Blood Marrow Transplant 20 (2014) 1282e12891284previously [9,10]; however, those studies evaluated HSPC
migration by placing both LL-37 and CXCL12 in the lower
well, and thus whether the results are derived from additive
effect of LL-37 or from preconditioning effect by synergy of
CXCL12 and LL-37 is unclear. To clarify this, we ﬁrst tested
whether LL-37 has a direct chemotactic effect on HSPCs and
found that LL-37 itself is a strong chemoattractant to BMNCs,
but not to clonogenic cells (Figure 1A). In accordance with
previous reports, we also found signiﬁcantly increased
migration of both BMNCs and CFU-M clonogenic cells was
signiﬁcantly in the presence of LL-37 with CXCL12 in the
lower well (Figure 1B).
We next evaluated the responsiveness of LL-37e
preconditioned BMNCs to CXCL12. Freshly prepared BMNCs
were conditioned with LL-37 for 30 minutes, after which
their migration to CXCL12 was tested. We found that the LL-
37 preconditioning effect was speciﬁc to CFU-Meforming
clonogenic cells, but not to other differentiated cells
(Figure 1C). We wondered whether this clonogenic cell-
speciﬁc effect is related to the phenomenon shown in
Figure 1A, which identiﬁed LL-37 as a strong chemo-
attractant only to BMNCs. To elucidate whether a remnant of
LL-37 causes a clonogenic-speciﬁc effect by inhibiting
migration of BMNCs to CXCL12, LL-37econditioned BMNCs
were washed thoroughly and used in migration assays. We
did not ﬁnd enhanced migration of BMNCs to CXCL12 even
after removing remnant LL-37, whereas clonogenic cell
migration was again enhanced (Figure 1D). This ﬁndingFigure 1. LL-37 enhances responsiveness of HSPCs to the CXCL12 gradient. Cell migrat
BMNCs responded to LL-37 as well as to CXCL12; however, LL-37edirected migration
LL-37 preconditioning effect was speciﬁc to clonogenic cells. (A) Migration of freshly
directed migration of BMNCs and HSPCs in the presence of LL-37. The migration o
Materials and Methods. In this setting, LL-37 was added to the lower chamber w
37epreconditioned cells were prepared by incubating BMNCs with LL-37 (500 nM)
migration of normal or LL-37epreconditioned cells. In this setting, LL-37epreconditio
transwell migration assay. Values (mean  SEM) represent fold increase. The data re
duplicate or triplicate. *P < .05. Filled bars, normal BMNCs; white bars, LL-37eprecoconﬁrms that LL-37 preconditioning selectively enhances the
responsiveness of clonogenic cells to CXCL12.
LL-37 Preconditioning Effects Are Related to Increased
Glucose Uptake and Calcium Inﬂux
To gain insight into why the LL-37 preconditioning effect
is speciﬁc to clonogenic cells, we performed in vitro migra-
tion assays in different conditions. Considering that mobi-
lized PB HSPCs usually show rapid reconstitution after
transplantation, unlike BM HSPCs [11], we hypothesized that
LL-37 preconditioning may affect the responsiveness of
HSPCs to exogenous factors present in plasma. At this point,
we suspected glucose, which may be the main energy source
in HSPCs that use glycolysis rather than mitochondrial
oxidative phosphorylation in BM niches [12]. In fact, the
CXCL12 directed migration of freshly prepared HSPCs was
signiﬁcantly attenuated in the absence of extracellular
glucose (Figure 2A). Moreover, the LL-37 preconditioning
effect almost disappeared when the LL-37epreconditioned
cells were used for migration assays in the glucose-free assay
media (Figure 2B). These results suggest that LL-37 may in-
crease glucose uptake and its metabolism for ATP production
through an unknown mechanism.
We next investigated the effect of LL-37 preconditioning
on the modulation of extracellular calcium inﬂux, because
calcium is an indispensable factor in chemotactic migration
[25]. HSPC migration was signiﬁcantly diminished in the
absence of extracellular calcium (Figure 2C), and LL-37ion assays were performed to evaluate the responsiveness of HSPCs to CXCL12.
s were restricted in the differentiated BMNCs and not in the SPCs, whereas the
prepared normal BMNCs and HSPCs to LL-37 gradient (500 nM). (B) CXCL12-
f HSPCs was scored on day 7 by counting CFU-M numbers as described in
ith CXCL12. (C) The migration of normal or LL-37epreconditioned cells. LL-
for 30 minutes. Note the HSPC-speciﬁc LL-37 preconditioning effect. (D) The
ned cells were thoroughly washed to remove remnant LL-37 and used for the
present the combined results of the 3 independent experiments performed in
nditioned BMNCs.
Figure 2. LL-37 preconditioning increases glucose uptake and calcium inﬂux. The effects of LL-37 preconditioning were evaluated using the transwell migration
assay. LL-37epreconditioned cells were thoroughly washed, resuspended with various assay media, loaded onto the upper chamber, and assessed for clonogenic cell
migration on day 7. (A) CXCL12-directed migration of freshly prepared BMNCs resuspended with normal glucose (5.5 mM) or glucose-free assay media. (B) Migration
of freshly prepared (ﬁlled bars) or LL-37epreconditioned (white bars) BMNCs after resuspension with normal glucose (5.5 mM) or glucose-free assay media. (C)
CXCL12-directed migration of freshly prepared BMNCs resuspended with normal or calcium-free (containing 5 mM EDTA) assay media. (D) Migration of freshly
prepared (ﬁlled bars) or LL-37 preconditioned (white bars) BMNCs after resuspension with normal or calcium-free assay media. Note the disappearance of LL-37
preconditioning effects in the absence of glucose or calcium. (E) Migration of control mediaepreconditioned (ﬁlled bar), LL-37epreconditioned (white bar), and
calcium-preconditioned (10 mM, bar with cross-stripes) BMNCs in response to CXCL12. Note that calcium preconditioning signiﬁcantly promoted the responsiveness
of clonogenic cells. The effect of calcium preconditioning was even stronger than that of LL-37 preconditioning. (F) CXCL12-directed migration of control mediae
preconditioned (ﬁlled bar), calcium- preconditioned (bar with cross- stripes), calcium and EDTAepreconditioned (5 mM, bar with mosaic), and EDTA- preconditioned
(bar with oblique line) BMNCs. Note that the presence of EDTA (5 mM) during calcium preconditioning abrogated the calcium preconditioning effect. Values
(mean  SEM) represent fold of migration and are the combined results representative of 3 independent experiments performed in duplicate or triplicate. *P < .05.
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CXCL12 in the absence of calcium (Figure 2D). More inter-
estingly, calcium (10 mM) preconditioning itself enhanced
clonogenic HSPC migration to CXCL12, and the conditioning
effect was even stronger than that of LL-37 (Figure 2E). The
migration of HSPCs preconditioned with calcium in the
presence of EDTA (Figure 2F) was not observed, however,
conﬁrming that that calcium inﬂux from extracellularsources contributes to the beneﬁcial effects of LL-37
preconditioning.
LL-37eaugmented Extracellular Calcium Mediated Cell
Signaling
Our in vitro migration study revealed that LL-
37eenhanced HSPC migration to CXCL12 is related to
elevated calcium inﬂux. To conﬁrm whether LL-37
H. Lee et al. / Biol Blood Marrow Transplant 20 (2014) 1282e12891286preconditioning mediates calcium inﬂux from extracel-
lular pools, we analyzed the changes in intracellular free
calcium level in the presence of LL-37. We used the HL-
60 cell line owing to difﬁculty obtaining sufﬁcient HSPCs
from BMNCs. HL-60 cells, known as relatively quiescent
cells, depend on glycolysis rather than oxidative phos-
phorylation as the primary energy source, like HSPCs [26].
We have found similar LL-37 preconditioning effects when
we used HL-60 cells instead of BMNCs (data not shown).
Both normal and LL-37e preconditioned HL-60 cells
without extracellular calcium showed similar transient
increases in intracellular free calcium when exposed to
extracellular calcium (Figure 3A), suggesting the ignorable
role of free calcium from internal pools after LL-37 pre-
conditioning. However, an increased extracellular calcium
concentration induced a strong and sustained calciumFigure 3. The effect of LL-37 preconditioning is dependent on extracellular calcium
through facilitating calcium inﬂux from extracellular calcium sources. Increased calciu
of 4E-BP1 and GSK-3b. (A) Changes in cytoplasmic free calcium levels in response to [
resuspended with calcium-free assay media. Cytoplasmic free calcium changes wer
representative of 3w5 independent experiments. (B) HL-60 cells were preconditioned
(0.5 mM [Ca2þ]o), and cytoplasmic free calcium changes were monitored. (C) Repr
different concentrations (0.5 mM, 2.5 mM, and 4.5 mM) for the indicated time point
experiments were quantiﬁed and normalized to b-actin using ImageJ. (D) HL-60 cell
(0.5 mM or 2.5 mM) for the indicated times in the presence or absence of LL-37 (500
(n ¼ 6; 2 independent experiments performed in duplicate). Note the LL-37 e
calciumecontaining media. *P < .05.inﬂux in LL-37epreconditioned cells (Figure 3B), indicating
that the increase in LL-37emediated cytoplasmic free cal-
cium originates from extracellular calcium, and that LL-37
preconditioning promotes increased calcium uptake in
HSPCs.
The fact that calcium triggersmTORC1 complex activation
[27] led us to investigate how enhanced calcium inﬂux af-
fects the metabolic status of HL-60 cells. HL-60 cells were
incubated up to 6 hours with different calcium concentra-
tions and subjected to immunoblot analysis. As shown in
Figure 3C, we found increased phosphorylation levels of 4E-
BP1 and GSK-3b at the downstream axis of mTORC1 in the
presence of calcium (2.5w4.5 mM). Extracellular calcium-
mediated mTORC1 activation was sustained up to 6 hours.
Whereas LL-37 did not affect cell viability in the presence
of normal calcium concentrations, it caused delayed[Ca2þ]o. LL-37 preconditioning augments the cytoplasmic free calcium level
m inﬂux activates the mTORC1 pathway, resulting in sustained phosphorylation
Ca2þ]o. HL-60 cells were preconditioned with LL-37 at 0 mM [Ca2þ]o and then
e monitored. Arrows indicate the addition of extracellular calcium. Data are
with LL-37 in 0.5 mM [Ca2þ]o and then resuspended with normal assay media
esentative immunoblotting of HL-60 cell lysates, stimulated with calcium at
s. The amounts of phosphorylated 4E-BP1 and GSK-3b from the 3independent
s (1  106 cells/mL) were maintained with different concentrations of calcium
nM). Extracellular calcium effects were scored by counting the number of cells
ffects in the 2.5 mM calciumecontaining media, but not in the 0.5 mM
H. Lee et al. / Biol Blood Marrow Transplant 20 (2014) 1282e1289 1287proliferation and apoptosis of HL-60 cells at high calcium
concentrations (Figure 3D).
LL-37 Preconditioning Impairs Long-Term Repopulation
Capacity, whereas AICAR Preconditioning Promotes
Long-Term Repopulation Capacity after Transplantation
Our in vitro study revealed that the LL-37 preconditioning
effect is mediated speciﬁcally by increased calcium inﬂux
with the activation of mTORC1 and its downstream signaling.Figure 4. LL-37 preconditioning impairs long-term repopulation capacity, whereas A
plantation. The same number of BMNCs (1  106 cells) derived from age-matched mal
irradiated C57BL/6 mice through the tail vein to test the long-term repopulation capa
the same procedures in the presence or absence of LL-37 (500 nM), LiCl (10 mM), or
resuspension. Contributions of control mediaepreconditioned (A), LL-37epreconditio
after transplantation were analyzed by comparing percent chimerism with the recov
from the recipient mice. The values (mean  SEM) represent the percentage of CD
dependent changes in chimerism versus 4 weeks were analyzed using repeated
preconditioned BMNCs was scored by counting the number of CFU-M colonies on
combined results of 3 independent experiments performed in duplicate or triplicate. (F
and AICAR-preconditioned HL-60 cells after stimulation with FBS (ﬁnal concentration,
The arrow indicates the addition of FBS. Data are representative of 4 independent exTo evaluate the long-term repopulation capacity of
differently preconditioned HSPCs, we performed in vivo
competitive long-term repopulation experiments with LL-
37epreconditioned CD45.1þ and normal CD45.2þ BMNCs as
competitors. In addition, we evaluated the repopulation ca-
pacity of GSK-3b inhibitor (LiCl)- or AICAR-preconditioned
CD45.1þ BMNCs to gain insight into the potential long-term
repopulation capacity of transplanted HSPCs. We found
that the average chimerism level of CD45.1þ peripheralICAR preconditioning promotes long-term repopulation capacity after trans-
e CD45.1 and CD45.2 congenic mice were mixed and transplanted into lethally
city of transplanted HSPCs. Both CD45.1 and CD45.2 BMNCs were subjected to
AICAR (2 mM). Procedures included a 30-minute preincubation, washing, and
ned (B), LiCl-preconditioned (C), and AICAR-preconditioned (D) CD45þ BMNCs
ery of competitor cells using ﬂow cytometry analysis on PB samples obtained
45.1þ cells from Gr-1þegated populations at each time point (n ¼ 5). Time-
-measures ANOVA-type statistics. (E) CXCL12-directed migration of AICAR-
day 15. The values (mean  SEM) are fold of migration and represent the
) Changes in intracellular free calcium levels in normal, LL-37epreconditioned,
1.5%). Note the attenuated calcium inﬂux in AICAR-preconditioned HL-60 cells.
periments. *P < .05.
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the normal mediaepreconditioned cell transplanted group
(Figure 4A), but that CD45.1þ granulocytes recovered from
the LL-37epreconditioned cell transplanted group showed
impaired repopulation starting at 8 weeks after trans-
plantation (Figure 4B). Temporal GSK-3b inhibition was not
related to the impaired long-term repopulation capacity, as
demonstrated by the normal function of LiCl-preconditioned
cells after transplantation (Figure 4C). Surprisingly, AICAR-
preconditioned HSPCs showed a dramatic increase in long-
term repopulation capacity after transplantation. Although
the repopulation of AICAR-preconditioned cells seemed
normal during the ﬁrst 4 weeks, we observed a late but
marked contribution of AICAR-preconditioned cells starting
at around 8 weeks (Figure 4D).
AICAR-preconditioned cells showed delayed CFU-M col-
ony formation (Figure 4E). CXCL12-directed migration of
AICAR preconditioning was not associated with enhanced
migration compared with normal mediaepreconditioned
cells when CFU-M colonies of migrated cells were enumer-
ated on day 7. However, more colonies appeared on day 15,
implying that AICAR preconditioning may let HSPCs lie
dormant rather than enhancing the migration of HSPCs to
CXCL12. AICAR preconditioning also attenuated calcium
inﬂux when cells were exposed to FBS (Figure 4F). This effect
may be related to the calcium clearance mechanism medi-
ated through AMPK activation [28]. Taken together, these
results suggest that the protection of HSPCs from extracel-
lular calcium inﬂux might be critical for the enhancing the
long-term repopulation capacity of transplanted HSPCs.
DISCUSSION
Various strategies to facilitate homing and engraftment of
transplanted HSPCs, including enhancing the responsivenessFigure 5. Current and future strategies for successful HSPC transplantation with a l
quiescent state and adapt to the hypoxic microenvironment by using glycolysis in BM
between the circulation in blood vessels and the lodgment in hematopoietic stem cell
such as increased oxygen tension, ﬂuctuations in various nutrients and calcium, wh
homing and engraftment typically focus on the activation of isolated HSPCs; howev
premature differentiation or senescence, resulting in BM failure after transplantatio
dormancy during the long journey of transplanted HSPCs.of HSPCs to CXCL12, have been proposed, and recent studies
have highlighted the physiological signiﬁcance of LL-37
preconditioning as a useful strategy for overcoming the
shortage of available HSPCs [9,10]. The present study was
performed to evaluate whether LL-37 preconditioning is
acceptable for clinical applications where long-term repo-
pulation capacity is a prerequisite even after facilitated
homing and engraftment.
HSPCs prepared from mobilized PB provide more rapid
reconstitution than BM-derived HSPCs, but have demon-
strated impaired long-term repopulation in an animal model
[11]. That ﬁnding raised a concern that LL-37 preconditioning
may possibly impair long-term hematopoietic capacity after
transplantation, as do mobilized HSPCs. We found that LL-37
preconditioning speciﬁcally enhanced the migration of clo-
nogenic cells (Figure 1), and that elevated glucose uptake and
increased calcium inﬂux from extracellular sources play key
roles in mediating the clonogenic cell-speciﬁc effects of LL-
37 preconditioning (Figure 2). Enhanced migration of
calcium-preconditioned HSPCs strongly supported the de-
pendency of the LL-37 preconditioning effects on calcium
inﬂux (Figure 2E and F).
Calcium inﬂux from extracellular pools was strong
enough to be sustained for a prolonged period (Figure 3A and
B), and the high concentration of extracellular calcium not
only increased the phosphorylation of 4E-BP1 and GSK-3b
(Figure 3C), but also induced caspase 3 activation (Figure 3D).
However, hyperactivation of mTORC1 is known to induce
premature exhaustion of HSPCs [29-31] as the disruption of
GSK-3b or AMPK progressively depletes HSPCs [20,32,33].
This led us to compare in vivo long-term repopulation ca-
pacity of HPSCs preconditioned with LL-37, LiCl, and AICAR.
Verifying our concerns, LL-37epreconditioned HSPCs
showed impaired long-term repopulation starting at 8weeksimited number of HSPCs. Long-term repopulating HSPCs are maintained in a
niches. In the clinical setting, it takes time for transplanted HSPCs to relocate
niches. During this process, HSPCs are inevitably subjected to various stressors,
ich may affect the fate of HSPCs. Previous and current strategies to enhance
er, these strategies may disrupt long-term repopulation capacity by inducing
n. Our study suggests that future strategies must be focused on maintaining
H. Lee et al. / Biol Blood Marrow Transplant 20 (2014) 1282e1289 1289after transplantation (Figure 4B). These results are also
consistent with our preliminary experimental data showing
decreased hematopoietic recovery. When the small number
of LL-37epreconditioned BMNCs (5  105 cells/mouse) were
transplanted without normal competitor BMNCs, the recip-
ient animals died at 8 to 16 weeks post-transplantation. In
contrast, the repopulation of AICAR- preconditioned cells
was delayed, but dramatically increased starting at 8 weeks
post-transplantation (Figure 4D). The delayed repopulation
of AICAR-preconditioned cells can be explained by the late
increase in CFU-M colonies when we plated AICAR pre-
conditioned BMNCs (Figure 4E). In addition, AICAR-
preconditioned cells demonstrated an attenuated calcium
inﬂux against an FBS challenge (Figure 4F). These results are
in agreement with the fact that mTORC1 inhibition not only
delays aging of HSPCs by preserving their self-renewal and
hematopoietic capacity [29], but also enhances long-term
hematopoietic reconstitution of ex vivo expanded hemato-
poietic stem cells by inhibiting senescence [34].
In the clinical setting, transplanted HSPCs must travel a
long way from the circulation in blood vessels to relocate in
BM hematopoietic stem cell niches. While this is occurring,
HSPCs are inevitably subjected to various stimuli, such as
increases in oxygen tension and ﬂuctuations in various nu-
trients, which may impair long-term repopulation capacity.
Although LL-37 preconditioning seems to facilitate homing
and engraftment by activating isolated HSPCs to respond
more efﬁciently to CXCL12, preconditioning may diminish
the capacity for long-term repopulation by inducing pre-
mature differentiation or senescence, resulting in BM failure
after transplantation (Figure 5). Thus, the results of the
present study suggest that future strategies aimed at
improving transplantation outcomes should consider main-
taining HSPCs in their dormant state and protecting them
from various stimuli during their long journey to their home.
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